Latham, Davis Polk Guide Psychedelic Co.'s SPAC Merger

By Katryna Perera (January 20, 2022, 5:25 PM EST) -- Special purpose acquisition company Silver Spike Acquisition Corp. II announced Thursday it had entered into an agreement with psychedelic pharmaceutical developer Eleusis to take the clinical-stage life sciences company public, in a deal that is expected to generate gross proceeds of up to $288 million....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!